Recruiting PHASE1/PHASE2 INTERVENTIONAL 1-arm
NCT07392541
Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer
A Single-Arm, Multicenter, Exploratory Clinical Study of Adebrelimab in Combination With Gemcitabine, Cisplatin, and Simvastatin for the Treatment of Patients With Locally Advanced or Metastatic Biliary Tract Malignancies
Sponsor: Tongji Hospital
Conditions
Advanced Biliary Tract Carcinoma
Interventions
Adebrelimab Gemcitabine + Cisplatin Simvastatin 20mg
Updated 1 time since 2026 Last updated: Jan 30, 2026 Started: Jan 30, 2026 Primary completion: Jan 30, 2028 Completion: Jan 30, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE1/PHASE2 clinical study on Advanced Biliary Tract Carcinoma, this trial is actively recruiting participants. The trial is conducted by Tongji Hospital and has accumulated 1 data snapshot since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Recruiting — PHASE1/PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Tongji Hospital
Data source: Tongji Hospital
For direct contact, visit the study record on ClinicalTrials.gov .